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Abstract Podocyte injury contributes to the development of
focal segmental glomerulosclerosis (FSGS). Endocapillary
hypercellularity, which is one of the pathological characteris-
tics of FSGS, suggests that glomerular endothelial injury may
also be involved in the pathogenesis of FSGS. In electron
micrographs of patients with FSGS (n = 43), we conducted
morphometric measurements of foot process width (FPW)
and podocyte detachment (PD) as markers of podocyte injury
and subendothelial widening (SW) of the glomerular base-
ment membrane as a marker of endothelial injury and com-
pared them to those in patients with minimal change nephrotic
syndrome (MCNS; n = 11) and control kidney donors (n = 5).
Associations between ultrastructural and clinical parameters
were analyzed according to the FSGS variants defined by
the Columbia classification. FPW was significantly higher in
the FSGS group than that in the MCNS and control groups,
particularly in the collapsing, tip, and cellular variants of
FSGS. Percentage of glomerular basement membrane
(GBM) length showing PD and SW was significantly in-
creased in the FSGS group, especially in the collapsing, cel-
lular, and not otherwise specified variants. In FSGS, FPWwas
inversely correlated with disease duration, but not with pro-
teinuria. Finally, the percentage of GBM length with SW sig-
nificantly correlated with clinical parameters indicative of
poor prognosis, such as lower remission rate and lower esti-
mated glomerular filtration rate at the final observation. Quan-
titative measurement of podocyte and endothelial injury by
electron microscopy might be useful for evaluating histologi-
cal activity and predicting prognosis in FSGS.
Keywords Electronmicroscopy . Focal segmental
glomerulosclerosis . Foot process effacement . Podocyte
detachment . Subendothelial widening
Introduction
Focal segmental glomerulosclerosis (FSGS) is morphologi-
cally defined by various histologic patterns of segmental glo-
merular lesions involving tuft capillary collapse, podocyte hy-
perplasia and hypertrophy, endocapillary hypercellularity,
sclerosis, and hyaline deposits. Podocytes are a major contrib-
utor in the pathogenesis of FSGS [9, 25]. Ultrastructural ab-
normalities of podocytes, such as foot process effacement [9,
25], vacuolization [32], cytoplasmic droplets [25], microvil-
lous transformation [21], and podocyte detachment (PD) from
the glomerular basement membrane (GBM) [9, 25], have been
reported in FSGS. Although these alterations are not specific
for FSGS, various morphological alterations of podocytes
suggest their importance in the pathogenesis of FSGS.
In 2004, D’Agati et al. proposed the Columbia classifica-
tion that identifies the following five histologic variants of
FSGS: collapsing (COL), tip (TIP), cellular (CEL), perihilar
(PH), and not otherwise specified (NOS) [3]. Among them,
the CEL variant is characterized by the presence of
endocapillary hypercellularity, intracapillary aggregates of
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endothelial cells, foam cells, and infiltrating leukocytes, which
results in capillary occlusion [3]. The significance of this le-
sion is unknown, but an immunohistochemical study has dem-
onstrated that the glomerular capillaries of the segmental le-
sion are negative for the endothelial marker CD31 [25], which
suggests that segmental lesion with endocapillary
hypercellularity may be a sign of endothelial damage and
endothelial injury may be involved in the development of
FSGS. Ultrastructural alterations representing endothelial
damage include endothelial swelling [7], decrease of the en-
dothelium or of its fenestrations [30], and subendothelial wid-
ening (SW) of GBM [20]. SW is characterized by the presence
of a lucent zone in the lamina rara interna and it is the most
frequent glomerular lesion attributed to endothelial damage
[17]. SW has been reported in human cases of endothelial
damage such as transplant glomerulopathy, thrombotic micro-
angiopathy, or hemolytic uremic syndrome, in which evolving
chronicity is occasionally accompanied by segmental glomer-
ular sclerosis [11, 16, 19, 26]. Therefore, it is quite conceiv-
able that podocyte and glomerular endothelial injury are in-
volved in the development of FSGS. A few morphometric
studies have evaluated podocyte abnormalities in FSGS [5,
31]. They focused on foot process effacement by quantitating
the foot process width (FPW), but other morphological alter-
ations of podocyte or endothelial damage have rarely been
examined. In this study, we morphometrically examined the
three parameters of FPW, PD, and SW ultrastructurally, be-
cause a quantitative approach was feasible in the electron mi-
crographs obtained from patients with FSGS. We compared
them with those in patients with minimal change nephrotic
syndrome (MCNS), which is widely accepted as
podocytopathy. The associations between ultrastructural and
clinical parameters were evaluated among FSGS variants de-
fined by the Columbia classification. Kidney transplant do-
nors served as controls.
Subjects and methods
Patients and controls
Forty-three patients with biopsy-proven FSGS cases were en-
rolled in this study. We excluded cases who were diagnosed
with other primary glomerular diseases, collagen diseases, or
diabetes, as well as cases associated with secondary FSGS
from various causes, such as obesity (body mass index
>28 kg/m2), renal atrophy, unilateral renal agenesis, reflux
nephropathy, family histories of renal diseases, or malignan-
cies [3]. Therefore, all cases were principally considered to
have idiopathic FSGS. The following data were collected
from the patients’ medical records: age, sex, disease duration,
proteinuria (g/day), and estimated glomerular filtration rate
(eGFR; mL/min/1.73 m2) at the time of biopsy. Proteinuria
and eGFR were also evaluated at the final observation. The
change in eGFR from the time of biopsy to the final observa-
tion was calculated and initiation of hemodialysis (HD) was
also reviewed. For comparison, we used renal biopsy speci-
mens from MCNS patients (n = 11) and zero-hour biopsy
specimens from control renal transplant donors (n = 5) who
showed no histologic abnormalities by light microscopy.
Some cases enrolled in this study were also subjects in our
previous study [29]. The study protocol and informed consent
procedure were approved by the ethics committee of the To-
kyo Women’s Medical University Hospital.
Light microscopy and immunofluorescence microscopy
The renal tissues were stained with hematoxylin and eosin,
periodic acid–Schiff, Masson’s trichrome, and periodic acid
methenamine silver. FSGS cases were classified into the fol-
lowing five variants according to the Columbia criteria [3]:
COL, TIP, CEL, PH, and NOS. Positive staining for segmen-
tal IgM and C3 was confirmed in cases of FSGS, whereas in
MCNS subjects or control donor, immunostaining was not
considered.
Electron microscopic examination
Specimens for electron microscopy were obtained at the time
of biopsy. The authors took eight randomly unbiased electron
microscopic photographs of glomeruli in each case, at magni-
fications of ×4000, ×4500, ×5000, and ×6000, with two pho-
tographs at each magnification. The following three parame-
ters were then measured with the image analysis software,
ImageJ (National Institute of Health, Rockville, MD, USA):
FPW, length of PD, and SW. FPWwas measured according to
a previously reported method [5].
In order to illustrate how the foot processes were counted
and length of PD and SWwasmeasured, electronmicroscopic
images of TIP (for the FPW: Fig. 1a–c), NOS (for PD:
Fig. 1d–f), and CEL variant (for SW: Fig. 1g–i) are shown
in Fig. 1, because foot process effacement was found in all
variants of FSGS including TIP variant, while PD and SW
were observed in NOS and CEL variants more often than in
other variants. Total length of GBM was measured (Fig. 1b),
and the number of podocytic foot processes was counted in
each GBM (Fig. 1c). A foot process was defined as cytoplas-
mic extensions, separated from adjacent foot processes by
lateral membranes (Fig. 1c) [5]. Separations between foot pro-
cesses were marked with arrowheads (Fig. 1c). For each pa-
tient, the mean FPW was calculated by dividing the total
length of GBM by the total number of intervals between the
foot processes.
In order to obtain GBM length showing PD or SW relative
to the total analyzed length of GBM (% of GBM length with
PD or SW, respectively), the total GBM length was measured
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(Fig. 1e, h), and the length of PD and SWwas measured in all
GBMs visualized on the electron micrographs (Fig. 1f, i). For
each patient, an average percentage of GBM length with PD
or SWwas calculated by dividing the total length of PD or SW
by the total length of GBM.
Definitions
Complete remission (CR) was defined as proteinuria
<0.3 g/24 h with a normal eGFR range (≥90 mL/min/
1.73 m2) at the final observation and/or with an im-
proved eGFR change from baseline (increase more than
+10 mL/min/1.73 m2). Partial remission (PR) was de-
fined as proteinuria between 0.3 and 2.0 g/24 h, with a
stabilized eGFR change between −10 and +10 mL/min/
1.73 m2. No response (NR) was defined as proteinuria
≥2.0 g/24 h with a progressive decrease in eGFR from
baseline (below less than −10 mL/min/1.73 m2). Renal
failure was defined as the clinical state requiring mainte-
nance HD.
Statistical analysis
The data are presented as the mean ± standard error of the
mean, geometric means with 95 % confidence intervals, or
mean as appropriate according to the data distribution. For
statistical analyses, Student’s t tests, Wilcoxon’s summed rank
tests or Kruskal–Wallis tests, Fisher’s exact tests, and multi-
variate linear regression analyses were used as appropriate. To
elucidate associations among the clinicopathological parame-
ters, Spearman correlation coefficients (r) were calculated. A
multivariate analysis was performed in a forward stepwise
fashion to determine the relationship between each of the ul-
trastructural parameters and clinical variables that were iden-
tified as being significant at P < 0.05 by univariate analysis.




Fig. 1 Electron micrographs (a–
i), illustrating the measurement of
the foot process width (FPW; a–
c), the length of podocyte
detachment (PD; d–f), and the
subendothelial widening (SW; g–
i) of the glomerular basement
membrane in the kidneys that
were obtained from patients with
the tip (TIP; a–c), not otherwise
specified (NOS; d–f) and cellular
(CEL; g–i) variants of FSGS. b, e,
h Length of the glomerular
basement membrane (GBM) on
electron microscopy determined
by the morphometric analysis
(yellow line). c An electron
micrograph illustrating the
separations of the foot processes
(arrowheads). f An electron
micrograph illustrating the
measurement of the length of
GBM with podocyte detachment
by two red lines. A podocyte is
intact in the area between the red
lines (arrow). i An electron
micrograph illustrating the
measurement of the length of
GBM with subendothelial
widening by two green lines.
GBM between the green lines is
the area where subendothelial
widening is not present (arrow)
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The analysis was performed with SPSS 14.0 for windows
(SPSS Inc. Japan, Tokyo, Japan).
Results
Clinical characteristics of patients with FSGS and MCNS
Clinical features of the FSGS and MCNS groups are sum-
marized in Table 1. Patients in the FSGS group demonstrat-
ed a significantly longer disease duration, particularly in
NOS and PH variants, compared to those in the MCNS
group (P < 0.01). At the time of biopsy, the eGFR in the
FSGS group was significantly lower than that in the MCNS
group (P < 0.01), and the degree of proteinuria was signif-
icantly lower in NOS and PH variants compared to other
variants of FSGS or to the MCNS group (NOS or PH
variant vs. MCNS group; P < 0.05). The controls had no
proteinuria, with a mean eGFR of 91.2 ± 9.2 mL/min/
1.73 m2.
At final observation, the degree of proteinuria was higher
and eGFR lower in the FSGS group than in the MCNS group
(P < 0.05, irrespective of the histological variant). No signif-
icant difference was detected in the change in eGFR between
the two groups, although the reduction in eGFR in the COL
and NOS variants was significantly greater than that in the
MCNS group (P < 0.05, Supplemental data 1). The percentage
of NR was significantly higher in the FSGS group,
particularly in the COL, CEL, and NOS variants, than that in
the MCNS group (P < 0.05). In contrast, 79% of patients with
the TIP variant showed CR or PR, and all patients with the PH
variant showed PR (data not shown). No significant difference
was detected in the overall percentage of patients needing HD
between the FSGS and MCNS groups, although 75 % of
patients with the COL variant required HD..
Representative figures of the FSGS variants
Representative electron microscopic images of each variant of
the FSGS,MCNS, and the control donor kidneys are shown in
Fig. 2. In micrographs of the control kidney, separations be-
tween foot processes were located at regular intervals on the
glomerular capillary (GC; Fig. 2a). In micrographs of MCNS
kidneys, GCs showed marked effacement of foot processes
(Fig. 2b). The GC showedmarked effacement of foot process-
es in micrographs from patients with the TIP variant (Fig. 2c)
as well as patients with the COL (Fig. 2d, e), CEL (Fig. 2f),
and NOS variants (Fig. 2g, h). In micrographs from patients
with the COL variant, parts of GCs were collapsed and
showed PD and SW (Fig. 2d, e). Furthermore, partial PD
and SW were apparent in patients with the CEL and NOS
variants (Fig. 2g, h, and PD in patients with the NOS variant
is also shown in Fig. 1d), but not in patients with other variants
or with MCNS. Patients with the PH variant demonstrated
preserved separations between foot processes, and slight ef-
facement of foot processes was partially observed (Fig. 2i).
Table 1 Clinical characteristics of patients with FSGS and MCNS
FSGS MCNS P valuea
All COL TIP CEL PH NOS
Case number 43 5 (11.6 %) 14 (32.6 %) 8 (18.6 %) 4 (9.3 %) 12 (27.9 %) 11
Age 38.8 ± 2.4 34.0 ± 3.2 41.2 ± 5.0 36.6 ± 2.7 34.8 ± 5.1 39.4 ± 4.8 34.6 ± 3.8 NS
Male/female 23/20 2/3 7/7 4/4 3/1 7/5 7/4 NS
Disease duration (months) 70.8 ± 14.8 12.5 ± 2.5 8.1 ± 3.5 20.6 ± 6.4 96.0 ± 44.3 102.1 ± 26.0 1.1 ± 0.1 <0.001
Initial urinary protein (g/day) 6.5 ± 1.0 6.7 ± 1.5 9.0 ± 2.1 10.3 ± 2.6 3.0 ± 1.4 2.0 ± 0.6 6.3 ± 0.8 NS
Initial eGFR (mL/min/1.73 m2) 53.4 ± 3.8 55.0 ± 16.1 52.6 ± 6.2 53.1 ± 22.8 54.3 ± 8.6 53.4 ± 8.5 82.5 ± 6.6 <0.01
Follow-up duration (years) 5.3 ± 0.4 4.0 ± 1.1 6.8 ± 0.7 4.4 ± 0.8 5.5 ± 1.0 4.5 ± 0.8 4.1 ± 0.7 NS
Final urinary protein (g/day) 1.24 ± 0.29 1.48 ± 0.63 0.97 ± 0.47 2.08 ± 1.04 0.62 ± 0.08 1.14 ± 0.49 0.05 ± 0.05 <0.001
Final eGFR (mL/min/1.73 m2) 43.1 ± 4.3 22.7 ± 11.8 50.0 ± 7.8 41.2 ± 28.0 57.3 ± 8.6 40.0 ± 7.9 84.2 ± 4.7 <0.001
△eGFR (mL/min/1.73 m2) −11.3 ± 4.9 −32.2 ± 10.0 −2.8 ± 10.4 −11.9 ± 11.6 3.0 ± 4.1 −13.4 ± 5.9 1.7 ± 4.2 NS
Remission (% of NR) 35.7 100 21.4 57.1 0 41.7 0 <0.05
Hemodialysis (%) 9/42 (21.4) 3/4 (75) 2/14 (14.3) 2/8 (25) 0/4 (0) 2/12 (16.7) 0/11 (0) NS
Quantitative variables are mean ± standard error
COL collapsing variant, TIP tip variant, CEL cellular variant, PH perihilar variant, NOS not otherwise specified variant, MCNS minimal change
nephrotic syndrome, eGFR estimated glomerular filtration rate, △eGFR eGFR at the final observation − eGFR at the time of biopsy, NR no response,
NS not significant
a Analysis of variance between all FSGS vs MCNS, Student t test, or Fisher exact test
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Morphometric analysis of FPW and the percentage of PD
and SW
The mean FPW was significantly higher in all groups of
FSGS (4004 ± 339 nm) and, to a lesser degree, of MCNS
(2926 ± 270 nm) than in that in control kidneys
(747 ± 68 nm, P < 0.05, Fig. 3a). The mean FPW was
significantly higher in patients with the COL, TIP, and
CEL variants than that in patients with other variants of
FSGS (P < 0.05, Fig. 3d), and patients with the CEL or
TIP variant had a significantly higher mean FPW than pa-
tients with MCNS (P < 0.05, Fig. 3b). The mean FPW was
lowest in the PH variant, but still significantly higher than
that in controls (P < 0.01).
The mean % of GBM length with PD was 3.0 ± 0.8 % in
patients with FSGS and 0.1 ± 0.1 % in MCNS (P < 0.05,
Fig. 3c). No significant difference was detected between
MCNS and control groups (0.1 ± 0.1 %). The mean % of
GBM length with PD was higher in patients with the COL,
CEL, and NOS variants than in those with other variants of
FSGS, MCNS, or controls (P < 0.05, Fig. 3d). The mean % of
GBM length with PD in patients with the TIP and PH variants
was not significantly different from that in controls.
The mean % of GBM length with SW was 13.0 ± 2.4 % in
patients with FSGS and 2.3 ± 1.6 % in MCNS (P < 0.01,
Fig. 3e). No significant difference was detected between
MCNS and control groups (3.7 ± 1.8 %). The mean % of












Fig. 2 Representative electronmicrographs of the kidneys from a control
donor (a), a patient with minimal change nephrotic syndrome (b), and
patients with each of the following variants of focal segmental
glomerulosclerosis (FSGS): tip variant (c), collapsing variant (d, e),
cellular variant (f), not otherwise specified variant (g, h), and perihilar
variant (i). In the micrographs of control kidney, separations between the
foot processes were located at regular intervals on the glomerular
capillary (a). In the micrographs of the MCNS kidneys, effacement of
the foot processes were marked (b). Foot process effacement was also
marked in the micrographs from patients with the TIP (c) the COL (d and
e), CEL (f), and NOS variants (g and h). Podocyte detachment and
subendothelial widening were apparent in the micrographs from
patients with COL, the CEL, and NOS variants (d, e, f, g, and h), but
not in patients with PH variant (i) or in patients with MCNS (b). CL—
capillary lumina, arrowheads—podocyte detachment, asterisk—
subendothelial widening, arrow—collapse of glomerular capillary


























































































































































































































Fig. 3 a Mean foot process width (a, b), percent podocyte detachment
(c), and percent subendothelial widening (e), with the 95 % confidence
interval in electron micrographs of the kidneys from patients with focal
segmental glomerulosclerosis (FSGS), patients with minimal change
nephrotic syndrome (MCNS), and control donors. b Mean foot process
width, percent of GBM length with PD (% of podocyte detachment; d)
and percent of GBM length with SW (% of subendothelial widening; f) in
electron micrographs of the kidneys from patients with each variant of
FSGS, patients with MCNS and control donors. *P < 0.05; **P < 0.01.
COL collapsing variant, TIP tip variant,CEL cellular variant, PH perihilar
variant, NOS not otherwise specified variant
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CEL, and NOS variants than in those with other variants of
FSGS (P < 0.05), MCNS, and controls (P < 0.01, Fig. 3f).
Morphometric data of mean foot process width; mean per-
centage of podocyte detachment; or subendothelial widen-
ing in FSGS, MCNS, and control patients are also shown
in Supplemental data 2.
Relations between clinical and ultrastructural parameters
in FSGS
The mean FPW in the FSGS group was associated with
shorter disease duration (r = −0.576; P < 0.01, Fig. 4a) and
the degree of proteinuria at the time of biopsy (r = 0.378,
P < 0.05, Fig. 4b). Multivariate analysis revealed that the
mean FPW in the FSGS group was associated with shorter
disease duration (P < 0.05), but not with proteinuria. No as-
sociation was detected between mean FPW and other ultra-
structural parameters.
The mean % of GBM length with PD in patients with
FSGS correlated with longer disease duration (r = 0.436,
P < 0.05) and the mean % of GBM length with SW
(r = 0.412, P < 0.05, Fig. 4c). On multivariate analysis, the
mean % of GBM length with PD was associated with the
mean % of GBM length with SW (P < 0.05), but not with
disease duration.
The mean % of GBM length with SW in patients with
FSGS was associated with the following clinical parameters:
lower eGFR (r = −0.413, P < 0.01) and proteinuria (r = 0.312,
P < 0.05) at the final observation, a greater reduction in eGFR
from the time of biopsy (r = −0.483, P < 0.01, Fig. 4d), and a
lower remission rate (r = −0.530, P < 0.01). On multivariate
analysis, the mean % of GBM length with SW was only cor-
related with the change in eGFR (P < 0.05). Figure 4e shows
the distribution of % of GBM length with SW according to
treatment response. Themedian% ofGBMwith SWwas 19.6
in patients with NR, 15 in PR, and 0.7 in CR (NR vs. PR or
CR; P < 0.05; Fig. 4e), and the median % of GBM length with
SW in NR was significantly higher than in PR or CR. There
was no statistical difference between CR and PR.
Discussion
The highly specialized podocyte plays a major role in the
glomerular filtration barrier. The podocyte foot process and
its associated slit membrane are finely organized structures
that maintain the filtration barrier, and their structural loss,
represented by foot process effacement, is considered a good
indicator of proteinuric glomerular disease. A few morpho-
metric studies have been performed to quantify foot process
effacement with the FPW parameter, and they have suggested
that the degree of FPW may be related to the underlying renal
disease [5, 31]. FPW in patients with MCNS was higher than
that in patients with proteinuric IgA nephropathy [31] and was
more extensive in patients with FSGS than those with MCNS
[5]. Our finding, that mean FPW in patients with FSGS is
significantly higher than that in patients with MCNS, supports
previously reported data. These findings indicate that quanti-
tative analysis of FPWmight be useful to distinguish between
FSGS and MCNS, particularly when a biopsy specimen does
not contain an adequate number of glomeruli.
The mean FPW in patients with FSGS was significantly
higher in the COL, CEL, and TIP variants than that in the
PH variant, with the NOS variant in between. The segmental
lesions in patients with the COL, CEL, and TIP variants are
histologically active with hypercellularity, caused by prolifer-
ation of intrinsic glomerular cells or infiltrating inflammatory
cells [3, 24], whereas segmental lesions in the PH and NOS
variants are characterized histologically by sclerotic lesions
that show an increase in extracellular matrix and hyaline de-
posits. Such pathological aspects are supported by clinical
data, in that patients with the COL, CEL, and TIP variants
developed severe proteinuria and had shorter disease duration.
Thus, the higher mean FPW in patients with the COL, CEL,
and TIP variants might represent more severe acute-phase
podocyte injury, whereas the lower mean FPW in patients
with the PH variant suggests less severe podocyte injury.
Differentiated podocytes are endowed with a limited po-
tential to divide [8]. As has been suggested by Kriz et al.,
in an ablation model of FSGS, tuft hypertrophy in response
to the reduced number of functioning nephrons does not
increase podocyte cell number, and podocytes are forced
to change their appearance, such as foot process efface-
ment, cell body attenuation, and finally detachment from
the GBM. Repair of such defects is only possible by hy-
pertrophy of adjacent intact podocytes, which is quite lim-
ited [14]. In our study, patients in the FSGS group demon-
strated a significantly higher % of GBM length with PD
than the control group, but not patients in the MCNS
group. PD has been reported in patients with several renal
diseases, including FSGS, diabetic nephropathy, amyloid-
osis, and reflex nephropathy [9, 12, 28, 30]; however, such
findings have rarely been observed in patients with MCNS
[15]. Our findings are consistent with the previously report-
ed results. The exact mechanisms responsible for PD in
patients with FSGS but not in those with MCNS remain
unclear. Recent studies have shown that dendrin, a protein
that promotes apoptosis of podocytes, is located in the cy-
toplasm of normal podocytes and in the kidneys of patients
with MCNS [6], whereas it translocates to the nucleus in
patients with FSGS [1]. These results suggest that regula-
tion of podocyte homeostasis and apoptosis in FSGS is
different from that in MCNS. Furthermore, we found the
% of GBM length with PD associated with longer disease
duration, suggesting that PD is an irreversible event,
reflecting severity and disease duration of FSGS. Taken
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together, podocyte injury culminates in detachment from
GBM, which may represent an end-stage manifestation of
podocytopathy in patients with FSGS.
SW is a morphological feature indicative of endothelial
injury. We found in the FSGS group a significantly higher %
of GBM length with SW than in the control group. Endothelial












































































































































Fig. 4 a Correlation between disease duration and mean foot process
width in individual patients with FSGS (white circles) and MCNS
(black triangles). b Correlation between proteinuria at the time of
biopsy and mean foot process width in individual patients with FSGS
(white circles) and MCNS (black triangles). c Correlation between
percent of GBM length with podocyte detachment (% of podocyte
detachment) and percent of GBM length with SW (% of subendothelial
widening) in individual patients with FSGS (white circles) and MCNS
(black triangles). d Correlation between change in eGFR and percent of
GBM length with SW (% of subendothelial widening) in individual
patients with FSGS (white circles) and MCNS (black triangles). e
Percent of GBM length with SW (% of subendothelial widening)
according to treatment response (NR non-response, PR partial
remission, CR complete remission). The % of subendothelial widening
was significantly increased in NR samples compared with PR or CR
samples (*P < 0.05). The horizontal line in the middle of each box
indicates the median; the top and bottom borders of the box mark the
75th and 25th percentiles, respectively; the whiskers mark the 90th and
10th percentiles; and the circles indicate outliers. Analysis of variance
followed by the Tukey post hoc test was used for the statistical analysis
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dysfunction has been recently observed in patients with
FSGS. In the Columbia classification, the CEL variant is de-
fined by the presence of endocapillary hypercellularity, which
consists of infiltrating foam cells and/or other inflammatory
cells together with swollen endothelial cells. These histologi-
cal features reflect endothelial injury. A recent report has sug-
gested that endothelial dysfunction in FSGS, which involves
increased levels of endothelial cell-derived circulating
VCAM-1 and thrombomodulin levels, is largely related to
disease activity [33]. Moreover, in an experimental model of
glomerulosclerosis, a reduced number of endothelial cells
were found, due to endothelial apoptosis [13]. These findings
suggest that endothelial injury is involved in the development
of FSGS.We excluded cases with secondary FSGS from anal-
ysis. However, we observed in cases with secondary FSGS
induced by calcineurin inhibitors after renal transplantation
that endothelial injury is more prominent than podocyte injury
(unpublished data). Further studies are needed to elucidate the
involvement of endothelial injury in the development of sec-
ondary FSGS.
Coexistence of podocyte and endothelial injury has been
reported in several human [22] and experimental renal dis-
eases [4, 13, 27]. A rat experimental model of endothelial
injury has demonstrated thickening of capillary walls from
SW and podocyte injury [23], which later resulted in
glomerulosclerosis [2]. In our study, the mean % of GBM
length with PD correlated with the mean % of GBM length
with SW in the FSGS group, and this was consistent with
in vivo experimental studies in a remnant kidney model [13,
27]. Furthermore, both parameters were higher in patients
with the COL, CEL, or NOS variants, and the mean % of
GBM length with SW was associated with a subsequent re-
duction in eGFR and a lower remission rate at the time of final
observation. The median % of subendothelial widening was
also significantly increased in NR samples compared with PR
or CR samples. The 75th percentile of % of GBM length with
SW was slightly higher in CR than in PR in our study. How-
ever, its median and 25th percentile was lower in CR than in
PR, and between PR and CR the differences were not signif-
icant. These findings indicate that PD and SW are important
factors in progression of FSGS, and both parameters might be
prognostic determinants.
Recent studies have suggested that crosstalk between
podocy t e s a nd endo t h e l i a l c e l l s may l e a d t o
glomerulosclerosis [4, 7]. Eremina et al. have established a
murine model in which vascular endothelial growth factor
(VEGF) production in podocytes is deleted [7]. These mice
show obliterated/collapsed glomerular capillaries with swol-
len endothelial cells, which suggests that VEGF production by
podocytes is required for homeostasis of adjacent glomerular
endothelium. Moreover, Daehn et al. induced experimental
glomerulosclerosis in which endothelin-1 and its receptor are
responsible for mitochondrial dysfunction, with PD as a result
of crosstalk between podocytes and endothelial cells, which
was mitigated by preventing mitochondrial oxidative stress in
endothelial cells [4]. Endothelial damage can occur because of
podocyte injury and plays a role in the development of
glomerulosclerosis in FSGS.
Based on its etiology, primary FSGS can be classified as
immunologic or genetic. Crosstalk between podocytes and
endothelial cells in genetic FSGS has not been well studied.
Electron microscopy of renal biopsies of multiple members of
two families with collapsing FSGS showed extensive wrin-
kling of the GBM, with extensive foot process effacement and
hypertrophy [18]. Irregularly aggregated electron-dense mate-
rial in podocyte cytoplasm has been reported as distinctive
ultrastructural feature of podocyte injury in ACTN4 biopsies
[10]. Further research is required to provide evidence of en-
dothelial injury in genetic FSGS.
In conclusion, we evaluated electron microscopic parame-
ters of FPWand PD as markers of podocyte injury and SWas
a marker of endothelial injury. Quantitative measurement of
FPWmay be useful to distinguish between FSGS and MCNS
and to evaluate histological activity in FSGS. Compared with
FPW, PD is a phenomenon more specific for FSGS,
representing a more severe and later manifestation of
podocyte injury. SW occurs also in patients with FSGS, and
quantitative evaluation of SW and PD might provide indica-
tors of prognosis in patients with FSGS. Further studies are
needed to evaluate their possible impact on the disease pro-
gression of FSGS.
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